Company / Interest Expense per Share
LEXICON PHARMACEUTICALS, INC. Interest Expense per Share History
FY2013-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.14
FY2019
5-year range
$0.06 / $0.14
FY2015-FY2019
Trend
+117.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2014 to $0.14 in FY2019.
Based on SEC 10-K filings.
0.14 in FY2019 with a 5-year CAGR of +99.9%.
Increased from $0.06 to $0.14 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +67.1%
- 5-Year CAGR
- +99.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, interest expense per share increased 117.7% year-over-year.
- Lowest interest expense per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2019 | $0.14 | +117.7% |
| FY2018 | $0.06 | -2.6% |
| FY2017 | $0.06 | +119.9% |
| FY2016 | $0.03 | +9.7% |
| FY2015 | $0.03 | +522.9% |
| FY2014 | $0.00 | -41.8% |
| FY2013 | $0.01 | -17.4% |
As of FY2019 · SEC 10-K Annual Filings · Updated Jun 24, 2026